MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Mao P, Manczak M, Shirendeb UP, Reddy HP Biochim Biophys Acta. 2013 Sep 19. PMID: 24055980. Abstract CommentRecommendBookmarkWatch